About Coriell Life Sciences
Coriell Life Sciences is a company based in Camden (United States) founded in 2013 was acquired by InformedDNA in March 2025. Coriell Life Sciences has raised $10.07 million across 2 funding rounds from investors including InformedDNA. Coriell Life Sciences offers products and services including Corigen and Research Analysis. Coriell Life Sciences operates in a competitive market with competitors including Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others.
- Headquarter Camden, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.07 M (USD)
in 2 rounds
-
Latest Funding Round
$9.47 M (USD), Series A
May 06, 2019
- Investors
-
Employee Count
Employee Count
-
Acquired by
InformedDNA
(Mar 19, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Coriell Life Sciences
Coriell Life Sciences offers a comprehensive portfolio of products and services, including Corigen and Research Analysis.
Improves medication efficacy through DNA testing and reduces healthcare costs.
Offers analysis for conditions like women's health and infections via genetic methods.
People of Coriell Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Coriell Life Sciences
Coriell Life Sciences has successfully raised a total of $10.07M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.47 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $9.5M
-
First Round
First Round
(19 Jul 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Series A - Coriell Life Sciences | Valuation |
investors |
|
| Jul, 2016 | Amount | Seed - Coriell Life Sciences | Valuation |
investors |
|
Investors in Coriell Life Sciences
Coriell Life Sciences has secured backing from 1 investor. Prominent investors backing the company include InformedDNA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Network of genetics experts provided to assist patients and providers.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Coriell Life Sciences
Financial Statements - Coriell Life Sciences
Coriell Life Sciences Comparisons
Competitors of Coriell Life Sciences
Coriell Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BAMF Health, InpharmD, BiomeSense and LifeOmic, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Platform for human genome study is provided for precision medicine.
|
|
| domain | founded_year | HQ Location |
AI-enabled molecular imaging and theranostics for disease diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Evidence-based drug information is provided to healthcare providers online.
|
|
| domain | founded_year | HQ Location |
AI-enabled platform for microbiome data generation and analysis is developed.
|
|
| domain | founded_year | HQ Location |
Storage, management and analysis of omic data for health applications
|
Frequently Asked Questions about Coriell Life Sciences
Coriell Life Sciences was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Coriell Life Sciences is headquartered in Camden, United States.
Coriell Life Sciences is a funded company, having raised a total of $10.07M across 2 funding rounds to date. The company's 1st funding round was a Seed of $605K, raised on Jul 19, 2016.
Coriell Life Sciences was founded in 2013 in Camden, United States, within the precision medicine sector. Platform technologies are utilized by clinicians to order genomic sequencing, obtain expert interpretations, and maintain secure storage of genomic data. The flagship product, GeneDose, is applied to buccal swabs from patients to forecast drug pharmacokinetics, metabolism, and potential adverse effects. Therapeutic solutions are provided across pain management, cardiology, gastroenterology, neurology, psychiatry, and additional fields.
Coriell Life Sciences's top competitors include Omega Therapeutics, CueZen and BAMF Health.
Coriell Life Sciences offers Corigen and Research Analysis.
Coriell Life Sciences has 1 investor. Key investors include InformedDNA.